# ENDRA Life Sciences Inc.: Form SCHEDULE 13D, filed Oct 8, 2026

- Company: [ENDRA Life Sciences Inc.](/companies/ndra.md) (CIK 1681682)
- Form: SCHEDULE 13D
- Filed: 2026-10-08
- Accepted by EDGAR: Oct 8, 2026, 16:15 ET
- Period: not reported
- Accession: 0001477932-26-006128
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1681682/000147793226006128/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1681682/000147793226006128/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1681682/000147793226006128/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Oct 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001477932-26-006128. Last ingested by Listed: Nov 6, 2026, 16:42 ET. No prices; not investment advice.